Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Analysis of the positive influence of hyperbaric oxygen therapy on the prognosis and hearing control of patients with noise-induced hearing loss.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Tan Z;Tan Z; Xu J; Xu J; Li J; Li J; You Y; You Y
- Source:
Noise & health [Noise Health] 2024 Oct-Dec 01; Vol. 26 (123), pp. 566-570. Date of Electronic Publication: 2024 Dec 30.
- Publication Type:
Journal Article
- Language:
English
- Additional Information
- Source:
Publisher: Medknow Publications Pvt. Ltd Country of Publication: India NLM ID: 9815620 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-4030 (Electronic) Linking ISSN: 14631741 NLM ISO Abbreviation: Noise Health Subsets: MEDLINE
- Publication Information:
Publication: 2007- : Mumbai : Medknow Publications Pvt. Ltd.
Original Publication: London, England : Noise & Health, 1998-
- Subject Terms:
- Abstract:
Objective: In this study, the research team aimed to explore the therapeutic effectiveness of hyperbaric oxygen therapy (HBOT) for noise-induced hearing loss (NIHL), its influence on patient prognosis, and its impact on hearing to provide valuable clinical evidence.
Methods: Ninety-four patients with NIHL admitted to The First People's Hospital of Changde City, Hunan, China, from May 2021 to January 2023 were selected for this retrospective analysis. Among them, 43 were given conventional treatment (control group) and 51 were given HBOT (observation group). The clinical efficacy, symptom improvement, and pure-tone hearing thresholds (PTHTs) at different frequencies were detected. All cases were followed up for 12 months to record the NIHL recurrence rates and hearing (hearing threshold), and their quality of life was investigated.
Results: The observation group had higher total effective rate and excellent rate and lower incidence of insomnia, tinnitus, and other symptoms than the control group (P < 0.05). PTHTs were lower in the observation group than in the control group at different frequencies (P < 0.05). Follow-up analysis showed no notable intergroup difference in the NHL recurrence rate (P > 0.05), but the hearing threshold was lower and the quality of life was better in the observation group than in the control group (P < 0.05).
Conclusions: Compared to conventional treatment, HBOT is effective in treating NIHL and can improve the hearing and coagulation function of patients and provide a reliable guarantee for their prognostic health.
(Copyright © 2024 Noise & Health.)
- References:
J Bone Joint Surg Am. 2022 Dec 7;104(23):2053-2058. (PMID: 36170382)
Diving Hyperb Med. 2020 Sep 30;50(3):244-249. (PMID: 32957126)
Otol Neurotol. 2012 Dec;33(9):1672-8. (PMID: 23007643)
Eur Arch Otorhinolaryngol. 2019 Jul;276(7):1859-1880. (PMID: 31111252)
Int J Mol Sci. 2020 Nov 14;21(22):. (PMID: 33202582)
Br J Hosp Med (Lond). 2019 Sep 2;80(9):525-529. (PMID: 31498679)
Healthcare (Basel). 2019 Dec 14;7(4):. (PMID: 31847309)
Medicina (Kaunas). 2022 Oct 10;58(10):. (PMID: 36295581)
Undersea Hyperb Med. 2015 Nov-Dec;42(6):539-46. (PMID: 26742254)
J Int Adv Otol. 2023 Oct;19(5):435-439. (PMID: 37789633)
Int J Mol Sci. 2019 Sep 20;20(19):. (PMID: 31547176)
Otol Neurotol. 2020 Sep;41(8):e971-e981. (PMID: 32740543)
Environ Health Prev Med. 2020 Oct 31;25(1):65. (PMID: 33129267)
J Anus Rectum Colon. 2023 Oct 25;7(4):264-272. (PMID: 37900689)
Neuroscience. 2022 Apr 15;488:77-95. (PMID: 35167939)
Eur Arch Otorhinolaryngol. 2011 Jan;268(1):49-56. (PMID: 20652293)
J Acoust Soc Am. 2020 Aug;148(2):884. (PMID: 32873002)
Int J Environ Res Public Health. 2021 Apr 22;18(9):. (PMID: 33922296)
- Publication Date:
Date Created: 20250109 Date Completed: 20250109 Latest Revision: 20250213
- Publication Date:
20250213
- Accession Number:
PMC11813235
- Accession Number:
10.4103/nah.nah_103_24
- Accession Number:
39787559
No Comments.